NEVVI Medicare utilization intelligence

← back

ROSS, JEREMYM.D. NPI 1013250455 Clinician

Hematology-Oncology · FORT WORTH, TX

Specialty Hematology-Oncology — from billed Medicare claims
In practice about 13 years since medical school (class of 2013, self-reported to CMS)
Location FORT WORTH, TX · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 43 codes billed · 55,702 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20212026
ONCOLOGY HEMATOLOGY CONSULTANTS, PA
2021–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2025-02

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1453 Injection, fosaprepitant, 1 mg
Q5110 Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram
J9271 Injection, pembrolizumab, 1 mg
J2469 Injection, palonosetron hcl, 25 mcg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J9190 Injection, fluorouracil, 500 mg
96375 Injection of additional new drug or substance into vein
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
88185 Flow cytometry technique for dna or cell analysis, each additional marker
96413 Administration of chemotherapy into vein, 1 hour or less
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J9045 Injection, carboplatin, 50 mg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96417 Administration of additional new drug or substance into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
96415 Administration of chemotherapy into vein, each additional hour
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J1200 Injection, diphenhydramine hcl, up to 50 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
71260 Ct scan of chest with contrast
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
74177 Ct scan of abdomen and pelvis with contrast
96372 Injection of drug or substance under skin or into muscle
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99441 Telephone medical discussion with physician, 5-10 minutes
96360 Infusion into a vein for hydration, 31-60 minutes
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
88184 Flow cytometry technique for dna or cell analysis, first marker
J7030 Infusion, normal saline solution , 1000 cc
99497 Advance care planning, first 30 minutes
78814 Nuclear medicine study limited area with ct scan
71250 Ct scan of chest without contrast
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
A9586 Florbetapir f18, diagnostic, per study dose, up to 10 millicuries
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
74176 Ct scan of abdomen and pelvis without contrast

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.